Gold nanoparticles show promise in helping restore vision in people with retinal disorders like macular degeneration.

A new study shows that gold nanoparticles injected into the retina can restore vision in mice with retinal degeneration, offering a less invasive alternative to current retinal prostheses.

Research indicates gold nanoparticles could restore eyesight in retinal disease patients, paving the way for non-invasive vision restoration techniques.

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Regeneron Pharmaceuticals ( NASDAQ: REGN) said on Thursday that the U.S. FDA will be reviewing the supplemental biologics license application ( (sBLA)) for Eylea HD injection, 8 mg, to treat macular ...

You've probably heard that carrots are good for your eyes, and it's true. Carrots are a super source of beta-carotene—and that's a start. But it takes a whole lot more to protect your irreplaceable ...

What to know about the whites and the yolks, including macronutrients, vitamins, minerals, whether you should eat the whole ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $831.43, with a high estimate of $1013.00 and a low estimate of $547.00. Highlighting a 8.86% ...

The Ohio State Medical Association has launched "Your Care is at Our Core" campaign in partnership with the AMA to advocate ...

Fenugreek seeds, are a hustler of health benefits that have been cherished in traditional drug for centuries. Packed with ...